The Journal of Small Animal Practice (JSAP)
The Journal of Small Animal Practice (JSAP) is the BSAVA's monthly scientific journal, featuring original, peer-reviewed articles, case reports and other scientific and educational information from around the world. The aim of JSAP is to facilitate the dissemination and implementation of new ideas and techniques relating to clinical veterinary practice, and ultimately to promote best practice.
JSAP is provided to BSAVA members as part of their membership benefits. Members - to access JSAP, log in then click on the 'read latest issues' button at the bottom of the page.
You can search for JSAP articles from within the BSAVA Library by clicking on the JSAP tab from the search results page. If you are a BSAVA member and already logged in, you can click through from the search results to access the full article.
You can view a selection of infographics which give a summary of JSAP papers on a variety of topics here.
December issue - in JSAP this month
Minimally invasive ultrasound-guided retrieval of extracavitary migrating foreign bodies is a plausible and successful technique, with an excellent long-term outcome and high owner satisfaction, a study in this month’s JSAP has confirmed. The overall complication rate was 19% (6 out of 32 dogs), with three major and three minor complications in the perioperative period. Full resolution of clinical signs was reported by all dog owners, and 94% would recommend this treatment instead of surgery to other pet owners. This technique offers significant advancement in patient care over traditional surgery for extracavitary foreign body removal, and merits being considered the preferred first-line option for the treatment of subcutaneous foreign bodies.
November issue - in JSAP this month
The neurodisability scale is a responsive tool to monitor meningoencephalitis of unknown origin (MUO) during treatment and relapse and can be used as a clinician-reported outcome measure in clinical trials, a study in this month’s JSAP has demonstrated. The study is the first to evaluate the responsiveness of the neurodisability scale (NDS) in a population of 38 dogs recently diagnosed with MUO, after initiation of treatment. The NDS was calculated at the time of diagnosis, 3-4 weeks after starting treatment and then at different timepoints depending on progress. The NDS demonstrated excellent responsiveness at both timepoints, and proved to be a responsive monitoring tool during MUO treatment and relapse. As the scale mostly relies on neurological examination findings and clinical history, which are always collected during examination of dogs with neurological dysfunction, it is easy to administer and doesn’t require additional interventions.
October issue - in JSAP this month
A study in this month’s JSAP has compared the clinical outcomes in dogs treated for sinonasal aspergillosis with different treatment approaches. Rhinoscopic debridement (RD) and trephination (TR) were the most commonly used treatment options for sinonasal aspergillosis in UK referral practices, with similar overall clinical remission rates (81% with RD, 69% with TR and 67% with sinusotomy/rhinotomy) in this study. However, the observed rate of complete clinical remission was lower than in previous studies. Oral antifungal monotherapy had no successful outcomes at any time point. The degree of debridement significantly influenced treatment outcomes, with rhinoscopic debridement in combination with topical antifungals showing the highest success rates. Adverse effects occurred in 24% of cases, most commonly with sinusotomy/rhinotomy and trephination. Treatment selection should be guided by clinician expertise, the extent of the disease, and equipment availability, given the lack of evidence for a single optimal approach.
You must be logged in and a BSAVA member (excluding veterinary nurse student member) to use the links.
A collection of JSAP reviews for primary care practice is freely available to all.
If you are not a member of BSAVA and wish to receive JSAP, you can either become a member or subscribe to the journal via our publisher, Wiley.